FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080145684> ?p ?o ?g. }

• W3080145684 endingPage "792" @default.
• W3080145684 startingPage "792" @default.
• W3080145684 abstract "Advanced glycation end products (AGEs) are produced through the binding of glycated protein or lipid with sugar, and they are known to be involved in the pathogenesis of both age-dependent and independent neurological complications. Among dicarbonyl compounds, methylglyoxal (MGO), which is produced from glucose breakdown, is a key precursor of AGE formation and neurotoxicity. Several studies have shown the toxic effects of bovine serum albumin (BSA)-AGE (prepared with glucose, sucrose or fructose) both in in vitro and in vivo. In fact, MGO-derived AGEs (MGO-AGEs) are highly toxic to neurons and other cells of the central nervous system. Therefore, we aimed to investigate the role of MGO-AGEs in microglial activation, a key inflammatory event, or secondary brain damage in neuroinflammatory diseases. Interestingly, we found that sulforaphane (SFN) as a potential candidate to downregulate neuroinflammation induced by MGO-AGEs in BV2 microglial cells. SFN not only inhibited the formation of MGO-AGEs, but it did not show breaking activity on the MGO-mediated AGEs cross-links with protein, indicating that SFN could potentially trap MGO or inhibit toxic AGE damage. In addition, SFN significantly attenuated the production of neuroinflammatory mediators induced by MGO-AGEs in BV2 microglial cells. SFN also lowered the expression levels of AGE receptor (RAGE) in microglial cells, suggesting that SFN could downregulate MGO-AGE-mediated neurotoxicity at the receptor activation level. Altogether, our current study revealed that SFN might show neuropharmacological potential for downregulating MGO-AGEs-mediated neuronal complications thorough attenuating AGE formation and neuroinflammatory responses induced by MGO-AGEs in vitro." @default.
• W3080145684 created "2020-09-01" @default.
• W3080145684 creator A5012503420 @default.
• W3080145684 creator A5016866322 @default.
• W3080145684 creator A5044288410 @default.
• W3080145684 creator A5089518405 @default.
• W3080145684 date "2020-08-26" @default.
• W3080145684 modified "2023-10-02" @default.
• W3080145684 title "Sulforaphane Inhibits MGO-AGE-Mediated Neuroinflammation by Suppressing NF-κB, MAPK, and AGE–RAGE Signaling Pathways in Microglial Cells" @default.
• W3080145684 cites W1581605409 @default.
• W3080145684 cites W1598235393 @default.
• W3080145684 cites W1603979475 @default.
• W3080145684 cites W1768846296 @default.
• W3080145684 cites W1830322222 @default.
• W3080145684 cites W1982345208 @default.
• W3080145684 cites W1990324489 @default.
• W3080145684 cites W1999769601 @default.
• W3080145684 cites W2006876937 @default.
• W3080145684 cites W2022647504 @default.
• W3080145684 cites W2023287697 @default.
• W3080145684 cites W2029388843 @default.
• W3080145684 cites W2031284093 @default.
• W3080145684 cites W2037141143 @default.
• W3080145684 cites W2085379310 @default.
• W3080145684 cites W2086247946 @default.
• W3080145684 cites W2097763382 @default.
• W3080145684 cites W2106216311 @default.
• W3080145684 cites W2111302710 @default.
• W3080145684 cites W2120293565 @default.
• W3080145684 cites W2140914384 @default.
• W3080145684 cites W2144725045 @default.
• W3080145684 cites W2153249592 @default.
• W3080145684 cites W2160239222 @default.
• W3080145684 cites W2161346457 @default.
• W3080145684 cites W2336640925 @default.
• W3080145684 cites W2375224166 @default.
• W3080145684 cites W2418030526 @default.
• W3080145684 cites W2571964874 @default.
• W3080145684 cites W2586083640 @default.
• W3080145684 cites W2587732406 @default.
• W3080145684 cites W2587838788 @default.
• W3080145684 cites W2593352740 @default.
• W3080145684 cites W2593393776 @default.
• W3080145684 cites W2613996502 @default.
• W3080145684 cites W2625268222 @default.
• W3080145684 cites W2669068909 @default.
• W3080145684 cites W2732175055 @default.
• W3080145684 cites W2749067209 @default.
• W3080145684 cites W2752834350 @default.
• W3080145684 cites W2766352370 @default.
• W3080145684 cites W2769928737 @default.
• W3080145684 cites W2776479976 @default.
• W3080145684 cites W2792236624 @default.
• W3080145684 cites W2794139372 @default.
• W3080145684 cites W2794281001 @default.
• W3080145684 cites W2801312164 @default.
• W3080145684 cites W2885385037 @default.
• W3080145684 cites W2892213316 @default.
• W3080145684 cites W2900520542 @default.
• W3080145684 cites W2903320548 @default.
• W3080145684 cites W2915298192 @default.
• W3080145684 cites W2921537979 @default.
• W3080145684 cites W2923962998 @default.
• W3080145684 cites W2994565609 @default.
• W3080145684 cites W4240182676 @default.
• W3080145684 doi "https://doi.org/10.3390/antiox9090792" @default.
• W3080145684 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7554773" @default.
• W3080145684 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32859007" @default.
• W3080145684 hasPublicationYear "2020" @default.
• W3080145684 type Work @default.
• W3080145684 sameAs 3080145684 @default.
• W3080145684 citedByCount "25" @default.
• W3080145684 countsByYear W30801456842020 @default.
• W3080145684 countsByYear W30801456842021 @default.
• W3080145684 countsByYear W30801456842022 @default.
• W3080145684 countsByYear W30801456842023 @default.
• W3080145684 crossrefType "journal-article" @default.
• W3080145684 hasAuthorship W3080145684A5012503420 @default.
• W3080145684 hasAuthorship W3080145684A5016866322 @default.
• W3080145684 hasAuthorship W3080145684A5044288410 @default.
• W3080145684 hasAuthorship W3080145684A5089518405 @default.
• W3080145684 hasBestOaLocation W30801456841 @default.
• W3080145684 hasConcept C104317684 @default.
• W3080145684 hasConcept C126322002 @default.
• W3080145684 hasConcept C127561419 @default.
• W3080145684 hasConcept C134018914 @default.
• W3080145684 hasConcept C147990577 @default.
• W3080145684 hasConcept C169760540 @default.
• W3080145684 hasConcept C170493617 @default.
• W3080145684 hasConcept C178790620 @default.
• W3080145684 hasConcept C181199279 @default.
• W3080145684 hasConcept C185592680 @default.
• W3080145684 hasConcept C203014093 @default.
• W3080145684 hasConcept C2776914184 @default.
• W3080145684 hasConcept C2778592357 @default.
• W3080145684 hasConcept C2778857457 @default.
• W3080145684 hasConcept C2779491297 @default.
• W3080145684 hasConcept C2779830541 @default.

• next